# MRI-Analysis-Project
This report presents an analytical overview of neurological imaging and statistical data obtained from the Fortune Neurological Clinic dashboard.

The dashboard integrates quantitative metrics, comparative brain scans, and statistical visualizations to assess disease progression, structural clarity, and pixel intensity variations in patients with varying degrees of cognitive impairment. The purpose of this report is to interpret the data in a structured manner, highlight clinical implications, and provide recommendations for further research and practice.

## Tools used 
1  Excel
2  Power bi
3  Python
4  Power POint

** Key Metrics Overview
Disease Progression: (1.50) Indicates early-stage progression, requiring monitoring.
Scan Disorder Level: (2.92) Suggests moderate abnormalities in brain scan patterns.
Radiance Progression: (74.67) Reflects elevated radiance levels, potentially linked to abnormal neural activity
Brightness Variation: (78.91) High variation, indicating inconsistent pixel intensity across scans
Center Brightness: (147.93) Elevated central brightness, possibly signifying focal abnormalities.

##Comparative Brain Scan Analysis:
- Top Disease Scans: Four images reveal abnormal neural patterns, with irregular pixel distribution and reduced structural clarity.
- Top Healthy Scans: Four images demonstrate normal brain activity, with consistent pixel intensity and well-defined structural clarity.
- Clinical Implication: The contrast between diseased and healthy scans underscores the diagnostic utility of pixel intensity and brightness variation metrics in differentiating pathological from non-pathological states.

- ## Interactive Dashboard
  [**Explore the Dashboard**](https://app.powerbi.com/view?r=eyJrIjoiNmRmNzIyYmItNDBmMC00ZDRlLWI1MjQtN2Q2ZTUzZWEyZDJhIiwidCI6ImU5MWVhMDBlLTRhYWItNDMyMC1iZDllLThjZDEwNTUxNTY1YSJ9)



#Interpretation:
- A clear downward trend in mean pixel intensity correlates with increasing severity of dementia.
- Standard deviation values also decrease, suggesting reduced variability in pixel distribution as disease progresses.
- This pattern supports the hypothesis that neurodegenerative progression diminishes structural complexity in brain imaging.

5. Neuroimage Entropy Levels
Entropy values reflect the randomness and complexity of brain scan data:
- 2.91 (24.68%)
- 2.92 (24.76%)
- 2.97 (25.21%)
- 2.99 (25.35%)
Interpretation:
Entropy remains relatively stable across categories, with minor fluctuations. This stability suggests that while pixel intensity decreases with disease severity, overall entropy does not drastically change, indicating persistent baseline complexity in neural imaging.

Interpretation:
Structural clarity declines progressively with disease severity. This metric strongly correlates with clinical observations of neurodegeneration, where brain structures lose definition and coherence over time.

7. Clinical Implications
- Early Detection: The dashboard metrics provide valuable indicators for identifying early-stage dementia through pixel intensity and brightness variation.
- Disease Monitoring: Quantitative measures such as entropy and structural clarity enable longitudinal tracking of disease progression.
- Diagnostic Support: Comparative imaging between healthy and diseased scans enhances diagnostic accuracy, supporting clinicians in differentiating subtle abnormalities.

8. Recommendations
- Integration with Clinical Records: Combine dashboard metrics with patient history for holistic diagnosis.
- Longitudinal Studies: Conduct repeated scans to validate progression trends over time.
- AI-Driven Analysis: Employ machine learning models to predict disease trajectory based on pixel intensity and entropy patterns.
- Cross-Population Validation: Expand dataset to diverse populations to ensure generalizability of findings.

9. Conclusion
The Fortune Neurological Clinic dashboard provides a robust framework for analyzing brain scans and quantifying disease progression. Key metrics such as pixel intensity, entropy, and structural clarity demonstrate strong correlations with dementia severity. These findings highlight the dashboardâ€™s potential as a clinical decision-support tool, offering both diagnostic and prognostic value in neurological practice.
